NCT06731582View on ClinicalTrials.gov

Nicotinamide Supplementation in Glaucoma

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

520

Participants

Timeline

Start Date

March 12, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2028

Conditions
Glaucoma
Interventions
DIETARY_SUPPLEMENT

Nicotinamide Tablet

1.5 grams/day

DIETARY_SUPPLEMENT

Nicotinamide Placebo

2 tablets

Trial Locations (2)

119074

National University Hospital, Singapore

168751

Singapore Eye Research Institute, Singapore

All Listed Sponsors
collaborator

National University Hospital, Singapore

OTHER

collaborator

Singapore National Eye Centre

OTHER_GOV

lead

Singapore Eye Research Institute

OTHER